If you use fluorescence or bioluminescence in your work, switch to autobioluminescene to get the same results faster and easier.
Ready to use autobioluminescent cell lines let you order today and start assaying tomorrow.
LiveLight™ continuously luminescent cell lines integrate into existing protocols with minimal modifications so you can immediately take advantage of autobioluminescence. Simply substitute them in place of the traditional bioluminescent or fluorescent cell you’re using now and begin assaying without worrying about when to excite or monitor. Each cell continuously produces an autobioluminescent signal proportional to its real-time metabolic activity level, providing unparalleled resolution on cellular response.
Specific autobioluminescent yeast strains for your unique application.
When you need to assay specifically for toxicity, estrogenicity, or androgenicity and need a robust, BSL1-level solution, an autobioluminescent yeast strain is your answer. These strains use the same autobioluminescent technology as our human cell lines, so you can be assured they will deliver the data you need without requiring human cell culture facilities.
We are constantly engineering new autobioluminescent cell lines.
We can modify your existing cell lines or samples to express an autobioluminescent phenotype and return them to your laboratory for in-house testing at a fraction of the cost of purchasing and maintaining an existing, substrate-requiring cell line. Need a custom assay for tracking gene expression? We can provide a one tube solution that works with any cell type.
490 BioTech is proud to serve as the industry’s premier provider of continuous, real-time, bioluminescent metabolic activity tracking assays.
These assays, which continuously and non-invasively track the metabolic dynamics of relevant cell types over prolonged exposure periods to identify the metabolic and cytotoxic effects of compounds both pre- and post-metabolism, are ideally suited to rapidly and cost-effectively position novel compound candidates for down-pipeline success. Contact us today to learn how our real-time bioluminescent monitoring approach can provide you with the pre-clinical development data you need to make more informed candidate selection decisions. Our approach provides an inexpensive alternative to in-house endpoint screens or costly out-sourcing alternatives so you can focus your time and resources on developing your next breakthrough candidate.
Autobioluminescence provides you with…